Hartland & Co »

Gt Biopharma shares owned by Hartland & Co

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Hartland & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $508 865 0.59
2025-06-30 $3.1k 865 3.58

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs Put Option (Principal) (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
NVIDIA Corporation (NVDA)
Wisdomtree Tr Us Largecap Divd (DLN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Hartland & Co

Top funds holding Gt Biopharma

DRW Holdings
Bank Of Montreal
Citadel Advisors
Geode Capital Management
Two Sigma Securities
Vanguard Group
Wells Fargo & Company
BlackRock
Advisor Group Holdings
Morgan Stanley
Newbridge Financial Services Group
UBS Group
Tower Research Capital
Hartland & Co
Jones Financial Companies, L.L

View all funds holding Gt Biopharma